Patents by Inventor Kenneth L. Rinehart

Kenneth L. Rinehart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090247533
    Abstract: The present invention is directed to several newly discovered ecteinascidin (Et) species, designated herein as Et 731, Et 815, Et 808, and Et 594. The physical properties of these compounds, their preparation and therapeutic properties are also reported.
    Type: Application
    Filed: June 11, 2009
    Publication date: October 1, 2009
    Applicant: The Board of Trustees of the University of Illinois
    Inventors: Kenneth L. Rinehart, Ryuichi Sakai
  • Publication number: 20080234279
    Abstract: The present invention is directed to several newly discovered ecteinascidin (Et) species, designated herein as Et 731, Et 815, Et 808, and Et 594. The physical properties of these compounds, their preparation and therapeutic properties are also reported.
    Type: Application
    Filed: October 30, 2007
    Publication date: September 25, 2008
    Inventors: Kenneth L. Rinehart, Ryuichi Sakai
  • Patent number: 7348311
    Abstract: Dehydrodidemnin B with useful biological activity has formula (1).
    Type: Grant
    Filed: May 23, 2005
    Date of Patent: March 25, 2008
    Assignee: Pharma Mar, S.A.
    Inventors: Kenneth L. Rinehart, Anna M. Lithgow-Bertelloni
  • Patent number: 7115743
    Abstract: The purification and structure elucidation of several products of the metabolism of Et 743 by human cytochrome CYP3A4 have been accomplished. These compounds are abbreviated herein as “ETM” followed by a numeric value which represents the approximate molecular weight. Three compounds have been identified to date, namely ETM 305, ETM 775 and ETM 204.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: October 3, 2006
    Assignee: Pharma Mar, S.A.
    Inventors: Kenneth L. Rinehart, Jose J. Morales, Joel Reid, Isabel Reymundo, Pablo Floriano, Lola Garcia Gravalos
  • Patent number: 7109244
    Abstract: Investigation of the activity of extracts of the clam Spisula polynyma has led to antitumor long-chain, straight-chain alkane or alkene compounds which have a 2-amino group and a 3-hydroxy group. The present invention is directed to compositions and methods comprising an isolated and purified long-chain, straight-chain 2-amino-3-hydroxyalkane, or prodrug thereof, and a pharmaceutically acceptable carrier, wherein the carbon chain in the long-chain, straight-chain 2-amino-3-hydroxyalkane is C16–C24.
    Type: Grant
    Filed: October 23, 2003
    Date of Patent: September 19, 2006
    Inventors: Kenneth L. Rinehart, Robert A. Warwick, Jesus Avila, Nancy L. Fregeau Gallagher, Dolores Garcia Gravalos, Glynn T. Faircloth
  • Patent number: 7060300
    Abstract: A bear derived isolate found in denning black bears or black bears from which food has been withheld for at least two weeks when injected into another mammal produces reduced heart rate, reduced respiratory rate, reduced temperature, and a wakeful tranquility not unlike the phenomena of the denning black bear. The isolate is taken from either the serum or urine of such denning bear. The method of the invention involves the steps of fractionating the serum or urine of a denning black bear to produce fractions of varying potency.
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: June 13, 2006
    Assignee: Carle Development Foundation
    Inventors: Ralph A. Nelson, Patricia G. Miers, Kenneth L. Rinehart
  • Patent number: 6867334
    Abstract: The purification and structure elucidation of several products of the metabolism of Et 743 by human cytochrome CYP3A4 have been accomplished. These compounds are abbreviated herein as “ETM” followed by a numeric value which represents the approximate molecular weight. Three compounds have been identified to date, namely ETM 305, ETM 775 and ETM 204.
    Type: Grant
    Filed: October 3, 2001
    Date of Patent: March 15, 2005
    Assignee: Pharma Mar, S.A.
    Inventors: Kenneth L. Rinehart, Jose J. Morales, Joel Reid, Isabel Reymundo, Pablo Floriano, Lola Garcia Gravalos
  • Patent number: 6855337
    Abstract: A bear derived isolate found in denning black bears or black bears from which food has been withheld for at least two weeks when injected into another mammal produces reduced heart rate, reduced respiratory rate, reduced temperature, and a wakeful tranquility not unlike the phenomena of the denning black bear. The isolate is taken from either the serum or urine of such denning bear. The method of the invention involves the steps of fractionating the serum or urine of a denning black bear to produce fractions of varying potency.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: February 15, 2005
    Assignee: Carle Development Foundation
    Inventors: Ralph A. Nelson, Patricia G. Miers, Kenneth L. Rinehart
  • Patent number: 6841530
    Abstract: Disclosed are semi-synthetic methods for the preparation of Didemnin Analogs. The compounds of this type are illustrated in Formula (I).
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: January 11, 2005
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Kenneth L. Rinehart, Alexandra J. Katauskas
  • Publication number: 20040209851
    Abstract: A bear derived isolate found in denning black bears or black bears from which food has been withheld for at least two weeks when injected into another mammal produces reduced heart rate, reduced respiratory rate, reduced temperature, and a wakeful tranquility not unlike the phenomena of the denning black bear. The isolate is taken from either the serum or urine of such denning bear. The method of the invention involves the steps of fractionating the serum or urine of a denning black bear to produce fractions of varying potency.
    Type: Application
    Filed: May 7, 2004
    Publication date: October 21, 2004
    Inventors: Ralph A. Nelson, Patricia G. Miers, Kenneth L. Rinehart
  • Patent number: 6800661
    Abstract: Investigation of the activity of extracts of the clam Spisula polynyma has led to antitumour long-chain, straight-chain alkane or alkene compounds which have a 2-amino group and a 3-hydroxy group.
    Type: Grant
    Filed: August 31, 1999
    Date of Patent: October 5, 2004
    Assignee: Board of Trustees of the University of Illinois
    Inventors: Kenneth L. Rinehart, Robert A. Warwick, Jesus Avila, Nancy L. Fregeau Gallagher, Dolores Garcia Gravalos, Glynn T. Faircloth
  • Publication number: 20040147615
    Abstract: Investigation of the activity of extracts of the clam Spisula polynyma has led to antitumour long-chain, straight-chain alkane or alkene compounds which have a 2-amino group and a 3-hydroxy group.
    Type: Application
    Filed: October 23, 2003
    Publication date: July 29, 2004
    Inventors: Kenneth L. Rinehart, Robert A. Warwick, Jesus Avila, Nancy L. Fregeau Gallagher, Dolores Garcia Gravalos, Glynn T. Faircloth
  • Publication number: 20040059112
    Abstract: The present invention is directed to several newly discovered ecteinascidin (Et) species, designated herein as Et 731, Et 745B, Et 815, Et 808, Et 596, Et 597, Et 583, Et 594 and a synthetic derivative of Et 594, N-Acetyl Et 597. The physical properties of these compounds, their preparation and bioactivities are also reported.
    Type: Application
    Filed: April 2, 2003
    Publication date: March 25, 2004
    Inventors: Kenneth L. Rinehart, Ryuichi Sakai
  • Patent number: 6710029
    Abstract: Dehydrodidemnin B with useful biological activity has formula (1). It can be isolated from natural sources or synthesized, and it forms active derivatives.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: March 23, 2004
    Assignee: Pharma Mar S.A.
    Inventors: Kenneth L. Rinehart, Anna M. Lithgow-Bertelloni
  • Publication number: 20030148933
    Abstract: Dehydrodidemnin with useful biological activity has formula (1). It can be isolated from natural sources or synthesized, and it forms active derivatives.
    Type: Application
    Filed: February 4, 2003
    Publication date: August 7, 2003
    Applicant: Pharma Mar S.A.
    Inventors: Kenneth L. Rinehart, Anna M. Lithgow-Bertelloni
  • Patent number: 6380156
    Abstract: Disclosed is a synthetic method for the preparation of analogs of Didemnin A (1), particularly the Amino-Hip analog of Didemnin A, also known as “AipDidemnin A” (8).
    Type: Grant
    Filed: June 28, 1999
    Date of Patent: April 30, 2002
    Assignee: The Board of Trustees of the University of Illnois
    Inventors: Kenneth L. Rinehart, Alexandra J. Katauskas
  • Publication number: 20020037835
    Abstract: Disclosed are semi-synthetic methods for the preparation of Didemnin analogs. The compounds of this type are illustrated in Formula (I).
    Type: Application
    Filed: September 10, 2001
    Publication date: March 28, 2002
    Inventors: Kenneth L. Rinehart, Alexandra J. Katauskas
  • Publication number: 20020032326
    Abstract: The purification and structure elucidation of several products of the metabolism of Et 743 by human cytochrome CYP3A4 have been accomplished. These compounds are abbreviated herein as “ETM” followed by a numeric value which represents the approximate molecular weight. Three compounds have been identified to date, namely ETM 305, ETM 775 and ETM 204.
    Type: Application
    Filed: October 3, 2001
    Publication date: March 14, 2002
    Inventors: Kenneth L. Rinehart, Jose J. Morales, Joel Reid, Isabel Reymundo, Pablo Floriano, Lola Garcia Gravalos
  • Patent number: RE38793
    Abstract: The present invention is directed to the isolation and bioactive characterization of compounds isolated from the clam Spisula polynyma. These compounds include three sphingoid-type bases, spisulosines 285, 299 and 313 (1-3), each of which shows unique cytotoxicity against L1210 murine lymphocytic leukemia cells. In addition, sphingosine (also referred to as 4-sphingenine or octadeca-4-shpingenine, 4) and two related compounds, nonadeca-4-sphingenine (a one carbon longer homolog, 5) and sphinga-4,10-diene (a dehydrosphingosine deravitive, 6) were also obtained, These compounds also contribute to the cytotoxicity of the Spisula polynyma extracts, but did not cause the morphology changes observed with compounds 1-3.
    Type: Grant
    Filed: August 14, 2002
    Date of Patent: September 6, 2005
    Inventors: Kenneth L. Rinehart, Nancy L. Gallagher, Robert A. Warwick
  • Patent number: RE39887
    Abstract: Dehydrodidemnin B with useful biological activity has formula (1). It can be isolated from natural sources or synthesized, and it forms active derivatives.
    Type: Grant
    Filed: June 2, 2005
    Date of Patent: October 16, 2007
    Assignee: Pharma Mar, S.A.
    Inventors: Kenneth L. Rinehart, Anna M. Lithgow-Bertelloni